James N. Wilson - 24 Feb 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson
Issuer symbol
CORT
Transactions as of
24 Feb 2026
Net transactions value
-$1.28
Form type
4
Filing time
26 Feb 2026, 16:45:03 UTC
Previous filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WILSON JAMES N Director C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson 26 Feb 2025 0001236387

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $388,000 +100,000 $3.88 100,000 24 Feb 2026 Direct
transaction CORT Common Stock Tax liability $388,001 -10,636 -11% $36.48 89,364 24 Feb 2026 Direct F1
transaction CORT Common Stock Gift $0 -89,364 -100% $0.000000 0 24 Feb 2026 Direct F2
transaction CORT Common Stock Other $0 +89,364 +8.6% $0.000000 1,134,532 24 Feb 2026 James N. Wilson and Pamela D. Wilson Trust F2, F3
holding CORT Common Stock 901,067 24 Feb 2026 James and Pamela Wilson Family Partners F3
holding CORT Common Stock 200,000 24 Feb 2026 James N. Wilson 2025 Grantor Retained Annuity Trust.
holding CORT Common Stock 200,000 24 Feb 2026 Pamela D. Wilson 2025 Grantor Retained Annuity Trust.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 +100,000 $0.000000 0 24 Feb 2026 Common Stock 100,000 $3.88 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 26, 2026.
F2 Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.
F3 Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
F4 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.